HK1011614A1 - Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin - Google Patents

Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin

Info

Publication number
HK1011614A1
HK1011614A1 HK98112731A HK98112731A HK1011614A1 HK 1011614 A1 HK1011614 A1 HK 1011614A1 HK 98112731 A HK98112731 A HK 98112731A HK 98112731 A HK98112731 A HK 98112731A HK 1011614 A1 HK1011614 A1 HK 1011614A1
Authority
HK
Hong Kong
Prior art keywords
tiazofurin
ribavirin
treatment
neoplastic disease
imp
Prior art date
Application number
HK98112731A
Other languages
English (en)
Inventor
George Weber
Original Assignee
Advanced Res & Tech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Res & Tech Inst filed Critical Advanced Res & Tech Inst
Publication of HK1011614A1 publication Critical patent/HK1011614A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HK98112731A 1993-05-18 1998-12-03 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin HK1011614A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/065,348 US5405837A (en) 1993-05-18 1993-05-18 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
PCT/US1994/004952 WO1994026281A1 (en) 1993-05-18 1994-05-05 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin

Publications (1)

Publication Number Publication Date
HK1011614A1 true HK1011614A1 (en) 1999-07-16

Family

ID=22062092

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112731A HK1011614A1 (en) 1993-05-18 1998-12-03 Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin

Country Status (14)

Country Link
US (1) US5405837A (xx)
EP (1) EP0707479B1 (xx)
JP (1) JP2951407B2 (xx)
KR (1) KR100310121B1 (xx)
AT (1) ATE208201T1 (xx)
AU (1) AU679531B2 (xx)
BR (1) BR9406534A (xx)
CA (1) CA2161970C (xx)
DE (1) DE69428995T2 (xx)
ES (1) ES2164703T3 (xx)
HK (1) HK1011614A1 (xx)
NZ (1) NZ266359A (xx)
RU (1) RU2149004C1 (xx)
WO (1) WO1994026281A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
US6720000B2 (en) * 2001-03-19 2004-04-13 Three Rivers Pharmaceutical, Llc Process for producing wet ribavirin pellets
BR0213861A (pt) * 2001-11-02 2004-12-21 Sandoz Ag Processo para a preparação de composições de ribavirina de carga elevada, de dissolução rápida
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
US7538094B2 (en) * 2002-09-19 2009-05-26 Three Rivers Pharmacueticals, Llc Composition containing ribavirin and use thereof
CA2572223C (en) * 2004-06-25 2014-08-12 The Johns Hopkins University Angiogenesis inhibitors
US8497292B2 (en) * 2005-12-28 2013-07-30 Translational Therapeutics, Inc. Translational dysfunction based therapeutics
KR101162710B1 (ko) * 2009-01-23 2012-07-05 (주) 비엔씨바이오팜 도라지 추출물 또는 도라지 사포닌 화합물을 함유하는 c형 간염의 예방 또는 치료용 약학적 조성물
WO2020123241A1 (en) * 2018-12-10 2020-06-18 Clear Creek Bio, Inc. Multiphasic dosing regimens for treating cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
US4680285A (en) * 1980-12-15 1987-07-14 Viratek, Inc. Treatment of malignant tumors with 2-(β-D-ribofuranosylthiazole-4-carboxamide related compounds
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment

Also Published As

Publication number Publication date
EP0707479A4 (en) 1998-04-15
DE69428995D1 (de) 2001-12-13
AU679531B2 (en) 1997-07-03
US5405837A (en) 1995-04-11
WO1994026281A1 (en) 1994-11-24
JPH08510450A (ja) 1996-11-05
CA2161970A1 (en) 1994-11-24
ES2164703T3 (es) 2002-03-01
RU2149004C1 (ru) 2000-05-20
KR960702313A (ko) 1996-04-27
NZ266359A (en) 1997-07-27
KR100310121B1 (ko) 2001-12-28
CA2161970C (en) 2005-06-21
EP0707479B1 (en) 2001-11-07
EP0707479A1 (en) 1996-04-24
BR9406534A (pt) 1996-01-02
JP2951407B2 (ja) 1999-09-20
AU6782794A (en) 1994-12-12
DE69428995T2 (de) 2002-06-06
ATE208201T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
MY109862A (en) A short infusion methods for administration of paclitaxel
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
HRP20070476T3 (en) Treatment of dependence withdrawal
PL345959A1 (en) Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
HK1011614A1 (en) Method for the treatment of neoplastic disease utilizing tiazofurin and ribavirin
DE69617729D1 (de) Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
EP0290262A3 (en) Improved nitrate therapy for angina pectoris
RU95122466A (ru) Способ лечения неопластического заболевания с помощью тиазофурина и рибавирина
Rossetti Single-shot vs conventional therapy with amikacin for treatment of uncomplicated urinary tract infections: a multicenter study
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU2132188C1 (ru) Способ лечения гипофункции щитовидной железы
何金森 et al. COMPARATIVE ANALYSIS OF THERAPEUTIC EFFECTS OF ACUPUNCTURE IN THE TREATMENT OF HYPERTHYROIDISM
RU93021361A (ru) Способ лечения экстрапирамидного синдрома при остром отравлении галоперидолом
Feuerstein et al. Single drug therapy with sodium valproate in primary generalized epilepsy. Phase 2: Long term efficacy and tolerance study.
袁硕 et al. 110 CASES OF MASTOSIS TREATED BY ACUPUNCTURE
葛通远 et al. AN APPROACH TO THE MECHANISMS OF LASER ACUPUNCTURE IN TREATMENT OF EXOPHTHALMIC HYPERTHYROIDISM
RU97117735A (ru) Способ лечения дифтерии
Eyben Phase II study of vindesine in patients with advanced breast carcinoma.
RU96104613A (ru) Способ лечения больных эндокринной офтальмопатией
RU96103669A (ru) Способ лечения саркоидоза
RU94045317A (ru) Способ лечения вилюйского энцефаломиелита
RU96124055A (ru) Способ лечения эпилепсии у детей
RU92007624A (ru) Способ лечения псориаза
UA30956A (uk) Спосіб лікування алергічного риніту

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060505